CTLA4 proteins and their uses

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9587007
APP PUB NO 20150051158A1
SERIAL NO

14524946

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE BIOTHERAPEUTICS INCREDWOOD CITY CA 94063

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akamatsu, Yoshiko Palo Alto, US 21 172
Dubridge, Robert B Belmont, US 54 1524
Juan, Veronica Redwood City, US 25 61

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00